Abbott Laboratories (ABT)

59.71
NYSE : Health Technology
Prev Close 58.99
Day Low/High 58.98 / 59.74
52 Wk Low/High 42.31 / 64.60
Avg Volume 6.78M
Exchange NYSE
Shares Outstanding 1.74B
Market Cap 102.68B
EPS 0.30
P/E Ratio 294.95
Div & Yield 1.12 (1.82%)

Latest News

Weekly Roundup

Markets rebound this week.

A Look Around Today's Market

As quick as last week's selloff occurred, this rebound higher has been just as fast, and we would not be surprised to see the market retest at some point.

Adding Amazon in Bullpen Reshuffle

Rearranging the bullpen to add four names, including Amazon, and drop four others, including Amex.

Roku, Amazon, Teladoc, Weyerhaeuser: 'Mad Money' Lightning Round

Roku, Amazon, Teladoc, Weyerhaeuser: 'Mad Money' Lightning Round

Jim Cramer highlights Roku, Amazon, Teladoc, Weyerhaeuser, Mondelez International, Mazor Robotics, and Kratos Defense & Security.

Volatility Is Still in Charge: Cramer's 'Mad Money' Recap (Friday, 2/9/18)

Volatility Is Still in Charge: Cramer's 'Mad Money' Recap (Friday, 2/9/18)

Jim Cramer tackles the volatility issue and outlines the game plan for next week.

Weekly Roundup

Markets extend losses in volatile week.

Nibbling at Abbott Labs

We are adding to our ABT position, as its stock is now getting absolutely no credit for a terrific Q4.

Abbott's App For FreeStyle® Libre System Now Available In Europe For Both IPhone™ And Android™

Abbott's App For FreeStyle® Libre System Now Available In Europe For Both IPhone™ And Android™

-- FREESTYLE LIBRELINK[1],[2] APP ENABLES FREESTYLE LIBRE USERS TO MONITOR THEIR GLUCOSE DIRECTLY WITH THEIR SMARTPHONE

How We Successfully Navigated the Past Week

Since last Tuesday, we effectively replaced what we sold for new buys, avoiding some of the large swoon in stocks.

Initiating a Position and Adding to Two Existing Ones

We want to jump on this weakness to put money to work.

Shopping For Values Amid the Carnage

The market slump is an opportunity for buyers.

We Are Buyers Down at These Levels

Nothing has changed with fundamentals, so 'good names' have gone on sale.

Looking at the Selloff, Updating Broadcom/Qualcomm

We are actively monitoring both our current holdings and bullpen names for any opportunities to scale in deeper or initiate a new position.

Cramer: 10 Points to Consider

Cramer: 10 Points to Consider

Don't worry about missing anything, we haven't solved the bond conundrum and the evidence says we get to 3% with selloffs on the way.

Weekly Roundup

Big market selloff

Our Strategy Amid This Market Volatility

This is why we added a blanket of protection earlier this week.

Jim's Daily Rundown

Jim discusses an analyst upgrade of Allergan, the super cycle concerns of Apple and how it impacts Broadcom, defense names in the bullpen, and a busy week of earnings.

Last Week's Portfolio Changes

We increased three price targets and upgraded another name as earnings season kicked into gear.

The 5 Best Dividend Aristocrats For 2018

The 5 Best Dividend Aristocrats For 2018

If you are looking for the best dividend stocks out there, look no further than these top dividend aristocrats.

Lam Research: Cramer's Top Takeaways

Lam Research: Cramer's Top Takeaways

Martin Anstice, president and CEO of Lam Research, tells Jim Cramer about the impact of silicon on our daily lives.

Diamondback Energy: Cramer's Top Takeaways

Diamondback Energy: Cramer's Top Takeaways

Jim Cramer says if you believe oil is heading higher, then you should be a believer in Diamondback Energy.

Super Bowl of Earnings: Cramer's 'Mad Money' Recap (Friday 1/26/18)

Super Bowl of Earnings: Cramer's 'Mad Money' Recap (Friday 1/26/18)

Politics, Davos, news -- none of it matters as much as earnings. Here's Jim Cramer's game plan for next week.

Axon Enterprise, WW Grainger: 'Mad Money' Lightning Round

Axon Enterprise, WW Grainger: 'Mad Money' Lightning Round

Jim Cramer highlights Axon Enterprise, WW Grainger, Maxim Integrated Products, Andeavor Logistics.

Weekly Roundup

Markets extend rally.

Jim's Daily Rundown

Jim discusses Honeywell and Abbott Labs earnings as well as Broadcom and the oils.

Illinois Tool Works: Cramer's Top Takeaways

Illinois Tool Works: Cramer's Top Takeaways

Scott Santi, chairman and CEO of Illinois Tool Works, tells Jim Cramer his company is making sophisticated technology more accessible to lesser skilled workers.

Dominion Energy, U.S. Concrete, AMD: 'Mad Money' Lightning Round

Dominion Energy, U.S. Concrete, AMD: 'Mad Money' Lightning Round

Jim Cramer's bullish on Dominion Energy, U.S. Concrete, Banco Santander, Republic First Bancorp, First Horizon National, and NVIDIA.

TheStreet Quant Rating: B- (Buy)